Universal Health Services Inc
UHS- Exchange
- NYSE
- Industry
- Services-General Medical & Surgical Hospitals, NEC
- SEC CIK
- 0000352915
No open-market purchases or sales by Universal Health Services Inc insiders were filed in the last 90 days; 595 institutions reported holding it in 13F filings for Q2 2026, worth $8.45B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Universal Health Services Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Universal Health Services Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Miller Alan B | Executive Chairman | 25,495Indirect | May 29, 2026 | 6 |
| Sussman Elliot J MD Mba | Director | 7,330 | May 21, 2026 | 3 |
| McDonnell Eileen C. | Director | 9,406 | May 21, 2026 | 1 |
| Nimetz Warren J. | Director | 9,698 | May 21, 2026 | 2 |
| Singer Maria Ruderman | Director | 9,792 | May 21, 2026 | 2 |
| Chen-Langenmayr Nina | Director | 4,267 | May 21, 2026 | 1 |
| Filton Steve | Executive Vice President & CFO | 144,715 | Mar 30, 2026 | 3 |
| Miller Marc D | President and CEO | 388,621 | Mar 30, 2026 | 4 |
| Peterson Matthew Jay | Executive Vice President, UHS | 31,984 | Mar 30, 2026 | 4 |
| Sim Edward H | Executive Vice President | 24,790 | Mar 30, 2026 | 3 |
| Gibbs Lawrence S. | Director | 2,230 | Mar 8, 2023 | 0 |
| Pember Marvin G. | Executive Vice President | 36,599 | Mar 25, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 13, 2026 (view filing) | Mar 11-13 | 2 days | Sussman Elliot J MD MbaDirector | SSaleClass B Common Stock | −674 | $190.06 | −$128.1K | −9.9%6.11K after | 2 lots |
| Nov 12, 2025 (view filing) | Nov 11 | 1 day | Nimetz Warren J.Director | SSaleClass B Common Stock | −3.82K | $223.31 | −$852.4K | −31.0%8.48K after | 2 lots |
| Oct 30, 2025 (view filing) | Oct 29 | 1 day | Sussman Elliot J MD MbaDirector | SSaleClass B Common Stock | −965 | $225.70 | −$217.8K | −13.6%6.11K after | |
| May 15, 2025 (view filing) | May 14 | 1 day | Singer Maria RudermanDirector | SSaleClass B Common Stock | −1.10K | $191.48 | −$210.1K | −12.2%7.88K after | |
| Mar 11, 2025 (view filing) | Mar 10 | 1 day | Singer Maria RudermanDirector | SSaleClass B Common Stock | −1.00K | $179.16 | −$179.2K | −11.2%7.92K after | |
| Dec 12, 2024 (view filing) | Dec 11 | 1 day | Singer Maria RudermanDirector | SSaleClass B Common Stock | −1.61K | $191.15 | −$308.5K | −21.5%5.88K after | |
| Aug 15, 2024 (view filing) | Aug 13 | 2 days | Sussman Elliot J MD MbaDirector | SSaleClass B Common Stock | −1.72K | $218.08 | −$375.5K | −25.4%5.05K after | |
| Aug 14, 2024 (view filing) | Aug 12 | 2 days | Nimetz Warren J.Director | SSaleClass B Common Stock | −3.44K | $217.64 | −$749.6K | −46.4%3.97K after | |
| Aug 8, 2024 (view filing) | Aug 7 | 1 day | Chen-Langenmayr NinaDirector | SSaleClass B Common Stock | −850 | $212.11 | −$180.3K | −30.0%1.99K after | |
| Jul 29, 2024 (view filing) | Jul 26 | 3 days | McDonnell Eileen C.Director | SSaleClass B Common Stock | −2.54K | $209.55 | −$531.2K | −28.3%6.41K after | |
| Jul 29, 2024 (view filing) | Jul 26 | 3 days | Sussman Elliot J MD MbaDirector | SSaleClass B Common Stock | −2.54K | $210.00 | −$533.6K | −33.5%5.05K after | |
| Jul 29, 2024 (view filing) | Jul 26 | 3 days | Peterson Matthew JayExecutive Vice President, UHS | SSaleClass B Common Stock | −15.1K | $210.85 | −$3.19M | −74.2%5.25K after | 2 lots |
| May 16, 2024 (view filing) | May 16 | Same day | Nimetz Warren J.Director | SSaleClass B Common Stock | −725 | $180.32 | −$130.7K | −15.4%3.97K after | |
| May 16, 2024 (view filing) | May 14 | 2 days | Singer Maria RudermanDirector | SSaleClass B Common Stock | −1.69K | $179.29 | −$302.8K | −34.8%3.17K after | |
| Mar 11, 2024 (view filing) | Mar 8 | 3 days | Filton SteveExecutive Vice President & CFO | SSaleClass B Common Stock | −35.0K | $176.82 | −$6.19M | −33.7%68.8K after | |
| Mar 5, 2024 (view filing) | Mar 4-5 | 1 day | Peterson Matthew JayExecutive Vice President, UHS | SSaleClass B Common Stock | −14.3K | $175.44 | −$2.50M | −96.9%458.99 after | 7 lots |
| Mar 4, 2024 (view filing) | Mar 1 | 3 days | Sussman Elliot J MD MbaDirector | SSaleClass B Common Stock | −3.49K | $170.99 | −$597.1K | −46.9%3.95K after | |
| Dec 19, 2023 (view filing) | Dec 1 | 18 daysLate | Chen-Langenmayr NinaDirector | SSaleClass B Common Stock | −1.41K | $138.64 | −$194.8K | −48.6%1.49K after | |
| Dec 19, 2023 (view filing) | Dec 6 | 13 daysLate | Chen-Langenmayr NinaDirector | PPurchaseClass B Common Stock | +250 | $136.73 | +$34.2K | +16.8%1.74K after | |
| Jun 14, 2023 (view filing) | Jun 13 | 1 day | Nimetz Warren J.Director | SSaleClass B Common Stock | −800 | $140.97 | −$112.8K | −21.4%2.94K after | |
| May 18, 2023 (view filing) | May 17 | 1 day | McDonnell Eileen C.Director | SSaleClass B Common Stock | −1.68K | $134.64 | −$226.2K | −24.0%5.32K after | |
| May 12, 2023 (view filing) | May 10 | 2 days | McDonnell Eileen C.Director | SSaleClass B Common Stock | −3.11K | $141.53 | −$439.7K | −36.1%5.51K after | |
| May 12, 2023 (view filing) | May 11 | 1 day | Nimetz Warren J.Director | SSaleClass B Common Stock | −500 | $139.01 | −$69.5K | −18.1%2.26K after | |
| May 12, 2023 (view filing) | May 11 | 1 day | Filton SteveExecutive Vice President & CFO | SSaleClass B Common Stock | −25.0K | $139.08 | −$3.48M | −21.0%93.8K after | |
| May 12, 2023 (view filing) | May 10 | 2 days | Miller Marc DPresident and CEO | SSaleClass B Common Stock | −44.1K | $142.65 | −$6.29M | −100.0%0 after | 3 lots |
| Mar 8, 2023 (view filing) | Mar 7 | 1 day | Gibbs Lawrence S.Director | SSaleClass B Common Stock | −793 | $122.31 | −$97.0K | −26.2%2.23K after | |
| Mar 6, 2023 (view filing) | Mar 3 | 3 days | Gibbs Lawrence S.Director | SSaleClass B Common Stock | −1.57K | $128.29 | −$201.2K | −34.2%3.02K after | |
| Mar 14, 2022 (view filing) | Mar 11 | 3 days | Gibbs Lawrence S.Director | SSaleClass B Common Stock | −1.31K | $153.00 | −$200.0K | −41.2%1.87K after | |
| Mar 1, 2022 (view filing) | Feb 28 | 1 day | McDonnell Eileen C.Director | SSaleClass B Common Stock | −296 | $141.17 | −$41.8K | −7.6%3.58K after | |
| Mar 1, 2022 (view filing) | Mar 1 | Same day | Gibbs Lawrence S.Director | SSaleClass B Common Stock | −985 | $143.84 | −$141.7K | −23.7%3.18K after | |
| Jul 28, 2021 (view filing) | Jul 28 | Same day | Gibbs Lawrence S.Director | SSaleClass B Common Stock | −314 | $160.00 | −$50.2K | −10.2%2.76K after |